A 22-year-old unmarried woman attends the family planning clinic 36 hours after a condom rupture during intercourse. She is unsure of her cycle dates but thinks she is somewhere in the middle of her cycle. She has no medical comorbidities and is not on any regular medications. She is very anxious and requests the most effective emergency contraceptive available. Which of the following is the MOST appropriate recommendation, considering both efficacy and the uncertainty about her cycle phase?

Explanation

## Emergency Contraception in Uncertain Cycle Phase **Key Point:** When cycle phase is unknown, ulipristal acetate is the safest and most effective choice because it maintains high efficacy across all cycle phases, including the periovulatory period when levonorgestrel is least effective. ### Why Cycle Phase Uncertainty Matters Levonorgestrel's efficacy varies dramatically by cycle phase: - **Follicular phase (days 1–7):** ~95% efficacy - **Periovulatory phase (days 8–14):** ~60–70% efficacy (LH surge may have begun) - **Luteal phase (days 15–28):** <50% efficacy (progesterone already elevated) Since the patient is "somewhere in the middle," there is significant risk she is in the periovulatory or luteal phase, where levonorgestrel fails. ### Comparison of Available Options | Agent | Mechanism | Efficacy Window | Efficacy | Best Phase | Limitation | |---|---|---|---|---|---| | **Levonorgestrel** | Progestin | ≤72 hrs | Phase-dependent (60–95%) | Follicular | Poor in luteal phase | | **Ulipristal acetate** | SPRMᵃ | ≤120 hrs | Phase-independent (95–99%) | All phases | Slightly higher cost | | **Mifepristone** | SPRM | ≤72 hrs | 85–90% | All phases | Regulatory restrictions in India | ᵃ SPRM = Selective Progesterone Receptor Modulator **High-Yield:** Ulipristal acetate's mechanism (blocking progesterone receptors) allows it to inhibit ovulation even when endogenous progesterone is rising, making it **phase-independent**. This is critical when cycle dates are uncertain. **Clinical Pearl:** At 36 hours post-intercourse, the patient is well within the 120-hour window for ulipristal acetate, and the uncertainty about cycle phase makes this the most rational choice to maximize contraceptive efficacy. **Mnemonic:** **ULIPRISTAL = UNIVERSAL** (works in all cycle phases, unlike levonorgestrel which is phase-dependent). **Warning:** Levonorgestrel should NOT be chosen when cycle phase is uncertain, as there is a real risk of being in the periovulatory or luteal phase where it has <70% efficacy. [cite:Park 26e Ch 15, WHO Medical Eligibility Criteria]